# A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer

> **NCT05934461** · — · COMPLETED · sponsor: **Laibin People's Hospital** · enrollment: 48 (actual)

## Conditions studied

- The Primary Study Metric is Progression-free Survival (PFS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05934461
- **Lead sponsor:** Laibin People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05934461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05934461, "A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05934461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*